EUVIMEDEUVIMED entdecken
Crossref

Can stratification biomarkers address the heterogeneity of autism spectrum disorder?

C J Molloy iD, L Gallagher

Irish Journal of Psychological Medicine · 2022-09 · 39 (3) · 305-311

DOI: 10.1017/ipm.2021.73 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Irish Journal of Psychological Medicine, online erschienen am 26.11.2021. Verfasst von C J Molloy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Autistic Disorder. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for biomarkers for autism spectrum disorder (henceforth autism) has received a lot of attention due to their potential clinical relevance. The clinical and aetiological heterogeneity of autism suggests the presence of subgroups. The lack of identification of a valid diagnostic biomarker for autism, and the inconsistencies seen in studies assessing differences between autism and typically developing control groups, may be partially explained by the vast heterogeneity observed in autism. The focus now is to better understand the clinical and biological heterogeneity and identify stratification biomarkers, which are measures that describe subgroups of individuals with shared biology. Using stratification approaches to assess treatment within pre-defined subgroups could clarify who may benefit from different treatments and therapies, and ultimately lead to more effective individualised treatment plans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderAutistic DisorderBiomarkersHumans

Stichwörter der Autor:innen

Autism spectrum disorderautismbiomarkersstratification

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland.

ORCID-Profile: C J Molloy

Zitieren

APA

Molloy, C. J., & Gallagher, L. (2022). Can stratification biomarkers address the heterogeneity of autism spectrum disorder?. Irish Journal of Psychological Medicine, 39(3), 305-311. https://doi.org/10.1017/ipm.2021.73

Vancouver

Molloy CJ, Gallagher L. Can stratification biomarkers address the heterogeneity of autism spectrum disorder?. Irish Journal of Psychological Medicine. 2022;39(3):305-311. doi:10.1017/ipm.2021.73

BibTeX
@article{Molloy2022,
  author = {Molloy, C J and Gallagher, L},
  title = {Can stratification biomarkers address the heterogeneity of autism spectrum disorder?},
  journal = {Irish Journal of Psychological Medicine},
  year = {2022},
  volume = {39},
  number = {3},
  pages = {305--311},
  doi = {10.1017/ipm.2021.73}
}
Kostenlos starten →